- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06556875
Regulation of HIIT Combined with IET on Vascular Function in Young Women with Normal Weight Obesity
October 24, 2024 updated by: Beijing Sport University
Comparison of the effects of combined IET with HIIT and HIIT on vascular function in young NWO women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a randomized clinical trial of single-blind with 3 arms (control group , HIIT group and IET with HIIT group), in which a pre-treatment-posttest design has been used.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China
- School of Sports Medicine and Rehabilitation, Beijing Sport University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Female, aged between 18 and 30 years old;
- BMI between 18.5 and 24.9 kg/m2 with a BF% > 30% (normal weight obesity determination criteria);
- exercise capacity to complete the exercise programme.
Exclusion Criteria:
- Acute or chronic musculoskeletal disorders, cardiovascular diseases, etc. that prevented training;
- other diseases (such as diabetes, etc.) that had a great impact on physical condition;
- bad habits (such as smoking, drinking, etc.);
- and unstable body weight (up and down fluctuations of more than 2.5 kg) in the 3 months before the experiment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
|
|
|
Active Comparator: HIIT group
|
high intensity interval training
|
|
Active Comparator: HIIT combined IET group
|
high intensity interval training combined with isometric exercise training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intima-Media Thickness (IMT)
Time Frame: 8 weeks
|
The subjects were required to sit still for 5~10 minutes before the test, and the carotid artery structural and functional parameters were recorded using a GE vivid 7 colour ultrasound instrument from the United States as follows: the subjects were required to lie in the supine position, and the probe was used to sweep longitudinally along the outer edge of the sternocleidomastoid muscle, and the maximal Intima-media thickness (IMT) was measured.
Changes in Intima media thickness before and after intervention.
|
8 weeks
|
|
Flow-Mediated Dilation (FMD)
Time Frame: 8 weeks
|
Vascular endothelial function was measured with a Japanese-made UNEX EF vascular endothelial function tester.
Pressure was applied on top of the resting blood pressure and the ischaemic process was performed for 5 min.
At the end of the ischaemic process, the pressure band was removed and flow-mediated dilation (FMD) of the brachial artery was calculated.
Changes in Flow-mediated dilation before and after Intervention
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Composition Indicators
Time Frame: 8 weeks
|
Body composition indicators analysis was assessed using DXA.
Body composition indicators include: fat mass(kg), lean body mass(kg), percentage of body fat(%).
|
8 weeks
|
|
Body Mass Index (BMI)
Time Frame: 8 weeks
|
Is calculated from the formula, Weight (kg) / Height2 (m2), whose unit is kg/m2.
It is a rough indicator of total body fat.
Changes in Body mass index before and after Intervention.
|
8 weeks
|
|
Blood Pressure (BP)
Time Frame: 8 weeks
|
Quiet blood pressure: Systolic and diastolic blood pressures are measured using a standard mercury sphygmomanometer.
Changes in blood pressure before and after intervention, including systolic blood pressure, diastolic blood pressure, and pulse pressure difference.
|
8 weeks
|
|
Pulse Wave Velocity (PWV) and ankle brachial index (ABI)
Time Frame: 8 weeks
|
The testing instrument is Omron Atherosclerosis Tester (BP-203RPEIII).
During the test, the subjects need to expose their limbs, lie flat on the bed, and keep their bodies relaxed.
At the same time, they need to tie cuffs around their limbs to avoid any physical movement and ensure the accuracy of the test results.
The unit of PWV is (cm/s), and ABI is a numerical value.
Changes in Pulse wave velocity and ankle brachial index before and after Intervention.
|
8 weeks
|
|
Volume Oxygen Maximum (VO2max)
Time Frame: 8 weeks
|
During the test, gradually increasing loads were performed using the Bruce running table protocol, and gas metabolism metrics were obtained at each stage of exercise using a portable Cortex-3B gas metabolism analyser.
Changes in Volume oxygen maximum before and after Intervention.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 23, 2023
Primary Completion (Actual)
September 30, 2023
Study Completion (Actual)
December 30, 2023
Study Registration Dates
First Submitted
July 27, 2024
First Submitted That Met QC Criteria
August 13, 2024
First Posted (Actual)
August 16, 2024
Study Record Updates
Last Update Posted (Actual)
October 28, 2024
Last Update Submitted That Met QC Criteria
October 24, 2024
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RHCIVFYWNWO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Weight Obesity
-
Oklahoma State UniversityRecruitingObesity | Normal-weight ObesityUnited States
-
Ball State UniversityRecruitingStress | BMI | Normal-weight ObesityUnited States
-
University Hospital, Clermont-FerrandAppetite Control and Energy Balance Research Group, UNiversity of Leeds,... and other collaboratorsTerminatedNormal Weight Adults | Adults With ObesityFrance
-
University of ZurichUniversity Hospital, ZürichCompleted
-
Oklahoma State UniversityAmerican Heart AssociationRecruitingNormal-weight ObesityUnited States
-
Pomeranian Medical University SzczecinNational Science Centre, PolandNot yet recruitingMetabolic Syndrome | Normal Weight Obesity | Metabolically Obese Normal WeightPoland
-
University of California, Los AngelesCompletedOverweight and Obesity | Normal WeightUnited States
-
University of California, DavisActive, not recruitingHealthy | Overweight | Obese | Normal WeightUnited States
-
University Hospital TuebingenRecruitingInsulin Resistance | Overweight and Obesity | Insulin Sensitivity | Normal WeightGermany
-
Vanderbilt University Medical CenterCompletedObesity | Insulin Resistance | Normal Weight,Healthy ControlsUnited States
Clinical Trials on HIIT
-
University of Erlangen-Nürnberg Medical SchoolUnknownMetabolic Syndrome | Overweight and ObesityGermany
-
Beijing Sport UniversityCompleted
-
Karabuk UniversityCompletedExercise Performance | Physical Fitness | Neuromuscular FunctionTurkey (Türkiye)
-
University of SevilleRecruitingInsulin Growth Factor I Deficiency | IGF1 Deficiency | Executive Function DisorderSpain
-
USDA Grand Forks Human Nutrition Research CenterCompletedObesity | OverweightUnited States
-
Karolinska InstitutetWithdrawn
-
University of Erlangen-Nürnberg Medical SchoolUnknownHealth Promotion | Primary PreventionGermany
-
Riphah International UniversityRecruiting
-
Hull University Teaching Hospitals NHS TrustTerminated
-
University of MaiaNot yet recruitingHigh Intensity Interval Exercise (HIIE)